Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Hartley

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
DNA sequence specificity of antitumor agents. Oncogenes as possible targets for cancer therapyJ A Hartley, J W Lown, W B Mattes, et al.
Methods in Molecular Medicine|March 5, 2011
Measurement of drug-induced DNA interstrand crosslinking using the single-cell gel electrophoresis (comet) assayV J Spanswick, J M Hartley, T H Ward, et al.
Nucleic Acids Research|August 11, 1993
A quantitative assay to measure the relative DNA-binding affinity of pyrrolo[2,1-c] [1,4]benzodiazepine (PBD) antitumour antibiotics based on the inhibition of restriction endonuclease BamHIM S Puvvada, J A Hartley, T C Jenkins, et al.
Nucleic Acids Research|June 25, 1994
DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cellsK A Grimaldi, S R McAdam, R L Souhami, et al.
Analytical Biochemistry|October 1, 1994
DNA damage by anticancer agents and its repair: mapping in cells at the subgene level with quantitative polymerase chain reactionK A Grimaldi, J P Bingham, R L Souhami, et al.
Cancer Research|October 1, 1985
Association of DNA strand breaks with accelerated terminal differentiation in mouse epidermal cells exposed to tumor promotersJ A Hartley, N W Gibson, L A Zwelling, et al.
Anti-Cancer Drug Design|July 20, 2000
Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agentsF M Anderson, C C O'Hare, J A Hartley, et al.
Cancer Research|February 1, 1986
2-Chloroethyl (methylsulfonyl)methanesulfonate (NSC-338947), a more selective DNA alkylating agent than the chloroethylnitrosoureasN W Gibson, J A Hartley, J M Strong, et al.
Biochemical Pharmacology|August 26, 1998
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activationS R McAdam, R J Knox, J A Hartley, et al.
The Journal of Pharmacy and Pharmacology|June 30, 2000
Anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcriptionV Gibson, R J Anderson, J A Hartley, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
DNA sequence specificity of antitumor agents. Oncogenes as possible targets for cancer therapyJ A Hartley, J W Lown, W B Mattes, et al.
Methods in Molecular Medicine|March 5, 2011
Measurement of drug-induced DNA interstrand crosslinking using the single-cell gel electrophoresis (comet) assayV J Spanswick, J M Hartley, T H Ward, et al.
Nucleic Acids Research|August 11, 1993
A quantitative assay to measure the relative DNA-binding affinity of pyrrolo[2,1-c] [1,4]benzodiazepine (PBD) antitumour antibiotics based on the inhibition of restriction endonuclease BamHIM S Puvvada, J A Hartley, T C Jenkins, et al.
Nucleic Acids Research|June 25, 1994
DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cellsK A Grimaldi, S R McAdam, R L Souhami, et al.
Analytical Biochemistry|October 1, 1994
DNA damage by anticancer agents and its repair: mapping in cells at the subgene level with quantitative polymerase chain reactionK A Grimaldi, J P Bingham, R L Souhami, et al.
Cancer Research|October 1, 1985
Association of DNA strand breaks with accelerated terminal differentiation in mouse epidermal cells exposed to tumor promotersJ A Hartley, N W Gibson, L A Zwelling, et al.
Anti-Cancer Drug Design|July 20, 2000
Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agentsF M Anderson, C C O'Hare, J A Hartley, et al.
Cancer Research|February 1, 1986
2-Chloroethyl (methylsulfonyl)methanesulfonate (NSC-338947), a more selective DNA alkylating agent than the chloroethylnitrosoureasN W Gibson, J A Hartley, J M Strong, et al.
Biochemical Pharmacology|August 26, 1998
KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activationS R McAdam, R J Knox, J A Hartley, et al.
The Journal of Pharmacy and Pharmacology|June 30, 2000
Anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcriptionV Gibson, R J Anderson, J A Hartley, et al.
Pageof 12